Filed with BSE · · 3 pages · English
This filing is a disclosure regarding changes in management at Mahamaya Lifesciences Limited following a recent meeting of the company's members. The resolutions approved include the appointment of Dr. Bhagirath Choudhary as an Independent Director and the reappointments of Dr. Gopal Krishna Raju and Dr. Charudatta Digambar Mayee as Independent Directors. Additionally, Mr. Krishnamurthy Ganesan will be re-designated as Chairman, while Mr. Prashant Krishnamurthy will become the new Managing Director. These changes are effective from specified dates as outlined in the filing.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Appointment of Dr. Bhagirath Choudhary as Independent Director, Re-appointment of Dr. Charudatta Digambar Mayee as Independent Director, Re-appointment of Mr. Gopal Krishna Raju as Independent Director, Re-designation of Mr. Krishnamurthy Ganesan as Chairman and Re-designation of Mr. Prashant Krishnamurthy as Managing Director pursuant to 24th Annual General Meeting held on September 29, 2026
Mahamaya Lifesciences Limited on 6ix
Follow Mahamaya Lifesciences into a list and get an email when it puts out news.
Follow Mahamaya Lifesciences